|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash | |||||||
| Prepaid expenses | |||||||
| Total Current Assets | |||||||
| Investment held in Trust Account | |||||||
| TOTAL ASSETS | |||||||
| LIABILITIES AND SHAREHOLDERS’ DEFICIT | |||||||
| Current liabilities - accrued expenses | |||||||
| Warrant liabilities | |||||||
| Deferred underwriting fee payable | |||||||
| Total liabilities | |||||||
| Class A ordinary shares subject to possible redemption, 85,147,760 shares at $10.06 per share and $10.00 per share redemption value at September 30, 2022 and December 31, 2021, respectively | |||||||
| SHAREHOLDERS’ DEFICIT | |||||||
| Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 1,920,000 shares issued and outstanding (excluding 85,147,760 shares subject to possible redemption) at September 30, 2022 and December 31, 2021 | |||||||
| Class B ordinary shares, $0.0001 par value; 50,000,000 shares authorized; 21,766,940 shares issued and outstanding at September 30, 2022 and December 31, 2021 | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Total Shareholders’ deficit | |||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT |
Loading...
